{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:36:09Z","timestamp":1761989769338,"version":"build-2065373602"},"reference-count":10,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5582\/irdr.2015.01039","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T03:13:58Z","timestamp":1450062838000},"page":"47-49","source":"Crossref","is-referenced-by-count":13,"title":["Spontaneous rectus sheath hematoma in a patient treated with apixaban"],"prefix":"10.5582","volume":"5","author":[{"given":"Halil","family":"Aktas","sequence":"first","affiliation":[{"name":"Departmant of Cardiology, Aksaray State Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Inci","sequence":"additional","affiliation":[{"name":"Departmant of Cardiology, Aksaray State Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Dogan","sequence":"additional","affiliation":[{"name":"Departmant of Cardiology, Aksaray State Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Izgu","sequence":"additional","affiliation":[{"name":"Departmant of Cardiology, Aksaray State Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P; European Heart Rhythm Association. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013; 15:625-651.","DOI":"10.1093\/europace\/eut083"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365:981-992.","DOI":"10.1056\/NEJMoa1107039"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos. 2009; 37:74-81.","DOI":"10.1124\/dmd.108.023143"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Cherry WB, Mueller PS. Rectus sheath hematoma: Review of 126 cases at a single institution. Medicine (Baltimore). 2006; 85:105-110.","DOI":"10.1097\/01.md.0000216818.13067.5a"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, Huber K, Jansky P, Steg PG, Hanna M, Thomas L, Wallentin L, Granger CB. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. J Am Coll Cardiol. 2014; 63:2141-2147.","DOI":"10.1016\/j.jacc.2014.02.549"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Pathak R, Pandit A, Karmacharya P, Aryal MR, Ghimire S, Poudel DR, Shamoun FE. Meta-analysis on risk of bleeding with apixaban in patients with renal impairment. Am J Cardiol. 2015; 115:323-327.","DOI":"10.1016\/j.amjcard.2014.10.042"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Hellwig T, Gulseth M. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: What do they mean for patients with atrial fibrillation? Ann Pharmacother. 2013; 47:1478-1487.","DOI":"10.1177\/1060028013504741"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Frost CE, Byon W, Song Y, Wang J, Schuster AE, Boyd RA, Zhang D, Yu Z, Dias C, Shenker A, LaCreta F. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. Br J Clin Pharmacol. 2015; 79:838-846.","DOI":"10.1111\/bcp.12541"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Cakar MA, Kocayigit I, Aydin E, Demirci H, Gunduz H. Clopidogrel-induced spontaneous pectoral hematoma. Indian J Pharmacol. 2012; 44:526-527.","DOI":"10.4103\/0253-7613.99342"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Tas Tuna A, Palabiyik O, Beyaz SG. Retracted: Spontaneous rectus sheath haematoma associated with rivaroxaban treatment. J Clin Pharm Ther. 2015; 40:486-488.","DOI":"10.1111\/jcpt.12228"}],"container-title":["Intractable & Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/5\/1\/5_2015.01039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T12:32:52Z","timestamp":1567427572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/5\/1\/5_2015.01039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2015.01039","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"type":"electronic","value":"2186-361X"},{"type":"print","value":"2186-3644"}],"subject":[],"published":{"date-parts":[[2015]]}}}